Trials / Completed
CompletedNCT00244556
Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
A Randomized Comparison of the Safety and Efficacy of Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Patients With Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To investigate the changes in MRI-derived markers of joint inflammation and destruction and in biochemical markers of connective tissue metabolism and angiogenesis in rheumatoid arthritis patients treated with Enbrel and Enbrel+methotrexate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methotrexate plus ENBREL or ENBREL alone |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2004-05-01
- Completion
- 2004-05-01
- First posted
- 2005-10-26
- Last updated
- 2013-02-21
Source: ClinicalTrials.gov record NCT00244556. Inclusion in this directory is not an endorsement.